Evidence map›Paper›PMID 24391468›Full record

ArticlePLoS biology2013

Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes.

Iben Lundgaard, Aryna Luzhynskaya, John H Stockley, Zhen Wang, Kimberley A Evans, Matthew Swire, Katrin Volbracht, Hélène O B Gautier, Robin J M Franklin, Charles Ffrench-Constant and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 214 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 1 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 1 synthesis or guideline pooled it, 329 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Mechanobiology of Myelin Generation/Regeneration in Health and Disease.Results and problems in cell differentiation · 2026
    Review
  15. The GluN3-containing NMDA receptors.Channels (Austin, Tex.) · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Iben LundgaardWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Aryna LuzhynskayaWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
John H StockleyWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Zhen WangDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Kimberley A EvansWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Matthew SwireMRC Centre for Regenerative Medicine, Centre for Multiple Sclerosis Research, University of Edinburgh, Edinburgh, United Kingdom.
Katrin VolbrachtWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Hélène O B GautierWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Robin J M FranklinWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Charles Ffrench-ConstantMRC Centre for Regenerative Medicine, Centre for Multiple Sclerosis Research, University of Edinburgh, Edinburgh, United Kingdom.
David AttwellDepartment of Neuroscience, Physiology & Pharmacology, University College London, London, United Kingdom.
Ragnhildur T KáradóttirWellcome Trust-Medical Research Council (MRC) Stem Cell Institute, John van Geest Centre for Brain Repair, and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Wellcome/MRC Cambridge Stem Cell Institute · GBMedical Research Council · GBUniversity of Edinburgh · GBUniversity College London · GBUniversity of Cambridge · GB

Funding

Medical Research Council G0701476Wellcome Trust 079249Wellcome Trust 079249/Z/06/AWellcome Trust 080513/Z/06/ZWellcome Trust 091543/Z/10/Z
6 · The paper itself

Abstract

Myelination is essential for rapid impulse conduction in the CNS, but what determines whether an individual axon becomes myelinated remains unknown. Here we show, using a myelinating coculture system, that there are two distinct modes of myelination, one that is independent of neuronal activity and glutamate release and another that depends on neuronal action potentials releasing glutamate to activate NMDA receptors on oligodendrocyte lineage cells. Neuregulin switches oligodendrocytes from the activity-independent to the activity-dependent mode of myelination by increasing NMDA receptor currents in oligodendrocyte lineage cells 6-fold. With neuregulin present myelination is accelerated and increased, and NMDA receptor block reduces myelination to far below its level without neuregulin. Thus, a neuregulin-controlled switch enhances the myelination of active axons. In vivo, we demonstrate that remyelination after white matter damage is NMDA receptor-dependent. These data resolve controversies over the signalling regulating myelination and suggest novel roles for neuregulin in schizophrenia and in remyelination after white matter damage.

Indexed as

Action PotentialsAnimalsBrain-Derived Neurotrophic FactorCoculture TechniquesFemaleMyelin SheathNeuregulin-1NeuregulinsOligodendrogliaRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateSignal TransductionBrain-Derived Neurotrophic FactorNeuregulin-1NeuregulinsNrg1 protein, ratReceptors, N-Methyl-D-Aspartate

Identifiers

PMID24391468
PMCPMC3876980
OpenAlexW2140916089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.